Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Advanced Ovarian Cancer. A Randomized Multicenter Phase ii Study (Primovar) von Mahner, S., Park, T.W., Ortmann, O., Hilfrich, J., Breitbach, G.P., Hoss, C., Mobus, V., Dietrich, K., Thomssen, C., Schwarz, J., Janicke, F., Kuhn, W.

Volltext

The value of neoadjuvant chemotherapy (NACT) after surgical-pathologic staging (SPS) vs. failed debulklng (FD) for inoperable ovarian cancer (IOC) and subsequent interventional lap... von Wallwiener, D., Breitbach, G.P., Bastert, G.

Volltext

00096: PRE-OPERATIVE SELECTION CRITERIA FOR OPERABILITY IN RECURRENT OVARIAN CANCER (DESKTOP-OVAR) von du Bois, A., Hahmann, M., Schroeder, W., Muenstedt, C., Schmalfeldt, B., Emons, G., Pfisterer, J., Wollschlaeger, K., Meerpohl, H.G., Breitbach, G.P., Tanner, B., Sehouli, J., Heilmann, V., Lueck, H.J., Kuhn, W., Wimberger, P., Ortmann, O., Harter, P.

Volltext

Adjuvant cisplatin and treosulfan chemotherapy in epithelial ovarian cancer stage I–III after complete surgical resection von Grischke, E.M., Felderbaum, R., Breitbach, G.P., Bastert, G.

Volltext

Gemcitabine combined with cisplatin as first-line treatment in patients 60 years or older with epithelial ovarian cancer: a phase II study von Bauknecht, T., Hefti, A., Morack, G., Villena-Heinsen, C., Wallwiener, D., Elling, D., Minckwitz, G.V., Mansouri, K., BLATTER, J., Breitbach, G.P.

Volltext

Uterine rupture — an analysis of 81 cases in Conakry/Guinea von Balde, M.D., Breitbach, G.P., Bastert, G.

Volltext

Effect of droloxifene treatment in metastatic breast cancer on tumor markers von Möbus, V., Breitbach, G.P., Kreienberg, R., Bastert, G., Staab, H.J.

Volltext

Drdloxifene: Efficacy and endocrine effects in treatment of metastatic breast cancer von Breitbach, G.P, Möbus, V., Bastert, G., Kreienberg, R., Huber, H.J., Staab, H.J.

Volltext